JPWO2023049475A5 - - Google Patents

Info

Publication number
JPWO2023049475A5
JPWO2023049475A5 JP2024518651A JP2024518651A JPWO2023049475A5 JP WO2023049475 A5 JPWO2023049475 A5 JP WO2023049475A5 JP 2024518651 A JP2024518651 A JP 2024518651A JP 2024518651 A JP2024518651 A JP 2024518651A JP WO2023049475 A5 JPWO2023049475 A5 JP WO2023049475A5
Authority
JP
Japan
Prior art keywords
oligonucleotide
conjugate
compound
subject
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518651A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024535388A (ja
JP2024535388A5 (https=
Publication date
Priority claimed from PCT/US2021/058495 external-priority patent/WO2022099159A1/en
Application filed filed Critical
Priority claimed from PCT/US2022/044765 external-priority patent/WO2023049475A1/en
Publication of JP2024535388A publication Critical patent/JP2024535388A/ja
Publication of JPWO2023049475A5 publication Critical patent/JPWO2023049475A5/ja
Publication of JP2024535388A5 publication Critical patent/JP2024535388A5/ja
Pending legal-status Critical Current

Links

JP2024518651A 2021-09-26 2022-09-26 オリゴヌクレオチド組成物及びその方法 Pending JP2024535388A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163248520P 2021-09-26 2021-09-26
US63/248,520 2021-09-26
PCT/US2021/058495 WO2022099159A1 (en) 2020-11-08 2021-11-08 Oligonucleotide compositions and methods thereof
USPCT/US2021/058495 2021-11-08
US202263331756P 2022-04-15 2022-04-15
US63/331,756 2022-04-15
US202263397320P 2022-08-11 2022-08-11
US63/397,320 2022-08-11
PCT/US2022/044765 WO2023049475A1 (en) 2021-09-26 2022-09-26 Oligonucleotide compositions and methods thereof

Publications (3)

Publication Number Publication Date
JP2024535388A JP2024535388A (ja) 2024-09-30
JPWO2023049475A5 true JPWO2023049475A5 (https=) 2025-10-07
JP2024535388A5 JP2024535388A5 (https=) 2025-10-07

Family

ID=85721200

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518651A Pending JP2024535388A (ja) 2021-09-26 2022-09-26 オリゴヌクレオチド組成物及びその方法

Country Status (11)

Country Link
US (1) US20250333740A1 (https=)
EP (1) EP4396354A4 (https=)
JP (1) JP2024535388A (https=)
KR (1) KR20240063964A (https=)
AU (1) AU2022352779A1 (https=)
CA (1) CA3232070A1 (https=)
CL (1) CL2024000856A1 (https=)
CO (1) CO2024005352A2 (https=)
IL (1) IL311625A (https=)
MX (1) MX2024003612A (https=)
WO (1) WO2023049475A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201500239VA (en) 2012-07-13 2015-03-30 Wave Life Sciences Japan Asymmetric auxiliary group
ES2917473T3 (es) 2014-01-16 2022-07-08 Wave Life Sciences Ltd Diseño quiral
CN108135921B (zh) 2015-07-22 2023-10-17 波涛生命科学有限公司 寡核苷酸组合物及其方法
CN109562122A (zh) 2016-06-03 2019-04-02 波涛生命科学有限公司 寡核苷酸、组合物及其方法
MA46905A (fr) 2016-11-23 2019-10-02 Wave Life Sciences Ltd Compositions et procédés de synthèse de phosphoramidites et d'oligonucléotides
US11718638B2 (en) 2017-06-21 2023-08-08 Wave Life Sciences Ltd. Compounds, compositions and methods for synthesis
CN111108096A (zh) 2017-09-18 2020-05-05 波涛生命科学有限公司 寡核苷酸制备技术
IL277889B2 (en) 2018-04-12 2025-01-01 Wave Life Sciences Ltd Oligonucleotide preparations and methods of using them
EP3790596A4 (en) 2018-05-11 2022-04-06 Wave Life Sciences Ltd. OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE
CN113748116A (zh) 2019-03-20 2021-12-03 波涛生命科学有限公司 可用于寡核苷酸制备的技术
WO2026077951A1 (en) 2024-10-07 2026-04-16 Vico Therapeutics B.V. Improved aon for rna editing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100048680A1 (en) * 2007-01-11 2010-02-25 University Of Florida Research Foundation Inc. Alpha-1-Antitrypsin Variants and Uses Thereof
JP2019516680A (ja) * 2016-05-04 2019-06-20 ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． オリゴヌクレオチド組成物およびその方法
WO2020001793A1 (en) * 2018-06-29 2020-01-02 Eberhard-Karls-Universität Tübingen Artificial nucleic acids for rna editing
KR20210126680A (ko) * 2019-02-13 2021-10-20 빔 테라퓨틱스, 인크. 알파-1 항트립신 결핍증을 치료하기 위한 조성물 및 방법
CN114585737A (zh) * 2019-10-06 2022-06-03 波涛生命科学有限公司 寡核苷酸组合物及其使用方法
EP4240849A4 (en) * 2020-11-08 2026-04-01 Wave Life Sciences Ltd OLIGONUCLEOTIDE COMPOSITIONS AND ASSOCIATED PROCESSES

Similar Documents

Publication Publication Date Title
JPWO2022099159A5 (https=)
JP5677716B2 (ja) オリゴヌクレオチド類似体を含むキット及び方法並びにオリゴヌクレオチド類似体の使用
US8080644B2 (en) Oligonucleotide analogues
US6670461B1 (en) Oligonucleotide analogues
US5399676A (en) Oligonucleotides with inverted polarity
US6593466B1 (en) Guanidinium functionalized nucleotides and precursors thereof
JPH05504553A (ja) 新規の結合を有するオリゴヌクレオチドアナログ
JPWO2023049475A5 (https=)
JPH06507883A (ja) メチレンホスホネートヌクレオシド類似体およびそれから作られるオリゴヌクレオチド類似体
JPH09511250A (ja) 核酸治療に有用な修飾オリゴヌクレオチド及び中間体
HU227794B1 (en) Oligonucleotide analogs compositions comprising same and process for producing them
JPH09506770A (ja) ｃ−ｅｒｂＢの発現が関与する疾患を予防及び治療するためのアンチセンス核酸
WO2019182037A1 (ja) 毒性が低減されたアンチセンスオリゴヌクレオチド
JPWO2019217708A5 (https=)
JP3142574B2 (ja) ２′，５′ホスホロチオエート／ホスホジエステルオリゴアデニレートおよびその抗ウィルス用途
TW202345861A (zh) 經修飾之間隔體寡聚物及其使用方法
JPH10508312A (ja) アミノ酸核酸
JPWO2019169219A5 (https=)
JPWO2023056446A5 (https=)
JPWO2023192630A5 (https=)
JPWO2023097291A5 (https=)
AU2002325599B2 (en) Oligonucleotide analogues
JPWO2023056440A5 (https=)